Meridian Bioscience Inc (VIVO)

17.45
NASDAQ : Health Care
Prev Close 17.35
Day Low/High 17.27 / 17.65
52 Wk Low/High 15.75 / 21.49
Avg Volume 246.40K
Exchange NASDAQ
Shares Outstanding 42.11M
Market Cap 730.58M
EPS 0.80
P/E Ratio 22.83
Div & Yield 0.80 (4.60%)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BBW, CMCO, FRBK, GLRE, HSII, VRTS, WEYS Downgrades: BID, BREW, ISIG, PSEC, SNE, VIVO Initiations: CCP, NVCR Read on to get TheStreet Quant Ratings' detailed report:

Meridian Bioscience is Oversold

Meridian Bioscience is Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc.

VIVO Crosses Above Key Moving Average Level

VIVO Crosses Above Key Moving Average Level

In trading on Monday, shares of Meridian Bioscience Inc. crossed above their 200 day moving average of $19.64, changing hands as high as $19.75 per share.

VIVO Crosses Above Average Analyst Target

VIVO Crosses Above Average Analyst Target

In recent trading, shares of Meridian Bioscience Inc. have crossed above the average analyst 12-month target price of $19.60, changing hands for $19.61/share.

10.8% of DGRS Holdings Seeing Recent Insider Buys

10.8% of DGRS Holdings Seeing Recent Insider Buys

A look at the weighted underlying holdings of the WisdomTree US SmallCap Quality Dividend Growth Fund (DGRS) shows an impressive 10.8% of holdings on a weighted basis have experienced insider buying within the past six months. START SLIDESHOW:10 ETFs With Stocks That Insiders Are Buying » Meridian Bioscience Inc.

VIVO: Insiders vs. Shorts

VIVO: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/29/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 18.18 "days to cover" versus the median component at 6.42.

Magellan Diagnostics Receives CFDA Clearance For LeadCare II In China

Magellan Diagnostics Receives CFDA Clearance For LeadCare II In China

Simple, portable diagnostic instrument used in thousands of US clinics will provide three-minute blood lead testing results to Chinese clinicians and parents.

Magellan Diagnostics Receives CFDA Clearance For LeadCare® II In China

Magellan Diagnostics Receives CFDA Clearance For LeadCare® II In China

Simple, portable diagnostic instrument used in thousands of US clinics will provide three-minute blood lead testing results to Chinese clinicians and parents

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

In trading on Friday, shares of Meridian Bioscience Inc. crossed below their 200 day moving average of $19.63, changing hands as low as $19.19 per share.

VIVO Crosses Above Average Analyst Target

VIVO Crosses Above Average Analyst Target

In recent trading, shares of Meridian Bioscience Inc. have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.13/share.

VIVO: Insiders vs. Shorts

VIVO: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 24.46 "days to cover" versus the median component at 6.60.

Meridian Bioscience Launches New Molecular Test For The Detection Of Mycoplasma Pneumoniae

Meridian Bioscience Launches New Molecular Test For The Detection Of Mycoplasma Pneumoniae

illumigene® Mycoplasma Direct provides fast and accurate results in less than 1 hour for immediate and targeted treatment

VIVO Breaks Above 4% Yield Territory

VIVO Breaks Above 4% Yield Territory

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Meridian Bioscience Inc. were yielding above the 4% mark based on its quarterly dividend (annualized to $0.80), with the stock changing hands as low as $19.96 on the day.

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

In trading on Tuesday, shares of Meridian Bioscience Inc. crossed below their 200 day moving average of $18.65, changing hands as low as $18.48 per share.

Ex-Dividend Reminder: Meridian Bioscience, New York REIT and Capital Bank Financial

Ex-Dividend Reminder: Meridian Bioscience, New York REIT and Capital Bank Financial

Looking at the universe of stocks we cover at Dividend Channel, on 2/4/16, Meridian Bioscience Inc. , New York REIT Inc , and Capital Bank Financial Corp will all trade ex-dividend for their respective upcoming dividends.